Cargando…
Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
SIMPLE SUMMARY: Patients with glioblastoma—the most frequent and malignant primary brain tumor—have a poor prognosis with a median survival of less than 15 months. Despite extensive research, treatment of glioblastoma has not improved since 2005. Most therapeutic strategies have focused on eliminati...
Autores principales: | Andersen, Rikke Sick, Anand, Atul, Harwood, Dylan Scott Lykke, Kristensen, Bjarne Winther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428223/ https://www.ncbi.nlm.nih.gov/pubmed/34503065 http://dx.doi.org/10.3390/cancers13174255 |
Ejemplares similares
-
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
por: Ma, Jun, et al.
Publicado: (2021) -
OTEH-4. Deeper insight into intratumoral heterogeneity by MRI and PET-guided stereotactic biopsies from glioblastoma patients
por: Anand, Atul, et al.
Publicado: (2021) -
Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy
por: Lin, Chao, et al.
Publicado: (2023) -
Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment
por: Codrici, Elena, et al.
Publicado: (2022) -
Macrophages in the Glioblastoma Tumor Microenvironment
por: Coniglio, Salvatore J.
Publicado: (2023)